Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of new therapeutic options for the treatment of uveal melanoma
Janney Z. Wang, Vivian Lin, Elsa Toumi, et al.
FEBS Journal (2021) Vol. 288, Iss. 21, pp. 6226-6249
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma
Paula Silva, Daniel Fernández‐Díaz, Manuel F. Bande, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3066-3066
Open Access | Times Cited: 56
Recent Advances and Challenges in Uveal Melanoma Immunotherapy
Yihang Fu, Wei Xiao, Yuxiang Mao
Cancers (2022) Vol. 14, Iss. 13, pp. 3094-3094
Open Access | Times Cited: 43
Melanoma biology and treatment: a review of novel regulated cell death-based approaches
Ming-yun Hsieh, Sheng‐Kai Hsu, Tzu‐Yu Liu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Nanomedicine: A pragmatic approach for tackling melanoma skin cancer
Vikram Mohanlal Prajapat, Srushti Mahajan, Priti Paul, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 83, pp. 104394-104394
Closed Access | Times Cited: 18
An update on inflammation in uveal melanoma
Sebastian Liau, Janney Z. Wang, Ethan Zagarella, et al.
Biochimie (2023) Vol. 212, pp. 114-122
Closed Access | Times Cited: 10
Erdafitinib promotes ferroptosis in human uveal melanoma by inducing ferritinophagy and lysosome biogenesis via modulating the FGFR1/mTORC1/TFEB signaling axis
Xue Zhu, Ling Wang, Ke Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 222, pp. 552-568
Closed Access | Times Cited: 3
Impact of tumour volume and treatment delay on the outcome after linear accelerator-based fractionated stereotactic radiosurgery of uveal melanoma
Shanthala Sreenivasa, Markus Wösle, Yann Gager, et al.
British Journal of Ophthalmology (2023) Vol. 108, Iss. 3, pp. 457-464
Open Access | Times Cited: 4
N6-methyladenosine methylation in ophthalmic diseases: From mechanisms to potential applications
Bingyan Li, Zicong Wang, Haixiang Zhou, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23668-e23668
Open Access | Times Cited: 4
Lapatinib-loaded reductive-responsive hyaluronic acid-cholesterol nanoparticles for inhibiting metastasis of uveal melanoma
Zhihao Guo, Cailing Wei, Jiangcheng Tan, et al.
International Journal of Biological Macromolecules (2024) Vol. 283, pp. 137028-137028
Closed Access | Times Cited: 1
Injectable nanocomposite hydrogel with cascade drug release for treatment of uveal melanoma
Zhihao Guo, Linyun Xiu, Yumei Li, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 1086-1099
Closed Access | Times Cited: 1
The unfolded protein response and the biology of uveal melanoma
Stanley Zhang, Ke Wang, Xue Zhu, et al.
Biochimie (2022) Vol. 197, pp. 9-18
Closed Access | Times Cited: 7
OUP accepted manuscript
Yihe Niu, Ke Wang, Xue Zhu, et al.
Journal of Pharmacy and Pharmacology (2022) Vol. 74, Iss. 5, pp. 660-680
Open Access | Times Cited: 7
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma
Wenying Shu, Xue Zhu, Ke Wang, et al.
Cellular Oncology (2022) Vol. 45, Iss. 4, pp. 601-619
Open Access | Times Cited: 7
Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition
Chandra C. Ghosh, Kara R. Heatherton, Kyle P. O’ Connell, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 12, pp. 1854-1865
Open Access | Times Cited: 6
Recent approaches for the treatment of uveal melanoma: Opportunities and challenges
Sauban Ahmed Khan, Waleed Hassan Almalki, Swaranjeet Arora, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104218-104218
Closed Access | Times Cited: 3
The ever‐expanding landscape of cancer therapeutic approaches
Christine J. Watson
FEBS Journal (2021) Vol. 288, Iss. 21, pp. 6082-6086
Open Access | Times Cited: 6
Evaluation of the Therapeutic Potential of Histone Deacetylase 6 Inhibitors for Primary and Metastatic Uveal Melanoma
Husvinee Sundaramurthi, Zoltán Giricz, Breandán N. Kennedy
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9378-9378
Open Access | Times Cited: 4
Modulation of AMPK Significantly Alters Uveal Melanoma Tumor Cell Viability
Özge Deliktaş, Mustafa Emre Gedik, İrem Koç, et al.
Ophthalmic Research (2023) Vol. 66, Iss. 1, pp. 1230-1244
Open Access | Times Cited: 2
Synthesis and evaluation of imidazo[1,2-a]pyrazine derivatives as small molecule Gαq/11 inhibitors against uveal melanoma
Junjie Deng, Lu Liu, Ge Yang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 239, pp. 114520-114520
Closed Access | Times Cited: 3
Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells
Wenying Shu, Janney Z. Wang, Xue Zhu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 18, pp. 3477-3495
Open Access | Times Cited: 1
The Role of Autophagy in Human Uveal Melanoma and the Development of Potential Disease Biomarkers and Novel Therapeutic Paradigms
Janney Z. Wang, Paus Paulus, Yihe Niu, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 462-462
Open Access
Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
Fanfan Zhou, Hong Zhu, Caiyun Fu
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 2
Quels traitements pour le mélanome uvéal ?
Evangelia Ch Papasotiriou, Emilie Chessel, Carla Costa, et al.
médecine/sciences (2022) Vol. 38, Iss. 8-9, pp. 733-736
Open Access | Times Cited: 1
Photon-based high-dose single-fraction radiosurgery, an effective treatment modality for recurrent uveal melanoma
Concetta Laliscia, Federica Genovesi-Ebert, Franco Perrone, et al.
Współczesna Onkologia (2023) Vol. 27, Iss. 2, pp. 109-112
Open Access
Unveiling similarities and differences between cutaneous and ocular melanomas
Abdallah Badou, Nour el Imane Issam Salah, M. Elbelhadji
Health Sciences (2023) Vol. 4, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top